Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | September 1, 1998 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00004033 |
| Study Type: | Interventional |
| Intervention: | Drug: liposomal NDDP|Procedure: therapeutic thoracoscopy |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | New York University School of Medicine|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 30 |
| Funded By: | Other|NIH |
| First Received: | December 10, 1999 |
| End Date: | |
| Last Updated: | March 17, 2010 |
| Last Verified: | March 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
